Skip to main content
Earnings Labs
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (ACRS)

NASDAQ·Healthcare·Biotechnology

$3.82

+0.66%

Mkt Cap $554.94M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (10 analysts)

$10.75

Range $10.00 – $12.00

Implied Upside

+181.8%

Consensus $10.75 vs current $3.82